HIV & AIDS

Trim the sugar: New HIV vaccine design improves immune response

A new HIV vaccine from Scripps Research has shown a significantly improved ability to neutralize the virus in preclinical tests, and it will soon be studied in healthy people who volunteer to participate in clinical trials.

Medical research

How human challenge trials accelerate vaccine development

Anna Durbin was in Brazil in December 2015 when the Zika virus erupted in the country's northeast. Although she'd flown to São Paulo to work on a dengue vaccine, Durbin returned to Baltimore preoccupied with Zika.

page 6 from 40